StonvexLoading…
StonvexStonvexStonvexCore line items from ALLY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.24B | $1.20B | $968.00M | $908.00M |
Operating Income | $1.05B | $836.00M | $1.10B | $2.34B |
Net Income | $852.00M | $668.00M | $957.00M | $1.71B |
EPS (Diluted) | $2.37 | $1.80 | $2.77 | $5.03 |
Total Assets | $196.00B | $191.84B | $196.33B | $191.83B |
Total Liabilities | $180.50B | $177.93B | $182.63B | $178.97B |
Cash & Equivalents | $10.03B | $10.29B | $6.95B | $5.57B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 308.49M | 305.39M | 302.46M | 299.32M |